Sclerosing cholangitis

Bailliere's Clinical Gastroenterology

Volumn 11, Issue 4, 1997, Pages 781-800

  Marotta, Paul J ^a   LaRusso, Nicholas F ^a,b   Wiesner, Russell H ^a,b  

^a Department of Medicine ^*

^b MAYO CLINIC   (United States)

Author keywords

Biliary tract; Cholangiocarcinoma; Cholangitis; Cholestasis; Chronic ulcerative colitis; Inflammatory bowel disease; Sclerosing cholangitis

Indexed keywords

BILIARY CIRRHOSIS; BIOCHEMISTRY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ENTERITIS; FATIGUE; HISTOLOGY; HUMAN; JAUNDICE; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PRURITUS; REVIEW; ULCERATIVE COLITIS;

EID: 0031471489     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(97)90021-X     Document Type: Article

References (55)

1. Abu-Elmagd KM, Malinchoc M, Dickson ER et al (1993) Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surgery, Gynecology and Obstetrics 177: 335-344.
2. Balasubramanian K, Wiesner RH & LaRusso NF (1988) Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 95: 1395-1399.
3. Bender CE, Wiesner RH, Leroy AJ et al (1991) Long-term benefit of percutaneous dilatation of dominant bile duct strictures in primary sclerosing cholangitis. Hepatology 14: 191A (abstract).
4. Bergasa NV & Jones EA (1993) The pruritus of cholestasis. Seminars in Liver Disease 13: 319-327.
5. Beuers U, Spengler U, Kruis W et al (1992) Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 16: 707-714.
6. Borkje B, Vetvik K, Odegaard S et al (1985) Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis. Scandinavian Journal of Gastroenterology 20: 539-542.
7. Brandt DJ, MacCarty RL, Charboneau JW et al (1988) Gallbladder disease in patients with primary sclerosing cholangitis. American Journal of Radiology 150: 571-574.
8. Burgert SL, Brown BP, Kirkpatrick RB et al (1984) Positive corticosteroid response in early primary sclerosing cholangitis. Gastroenterology 86: 1037 (abstract).
9. Chapman RW, Varghese Z, Gaul R et al (1983) Association of primary sclerosing cholangitis with HLA-B8. Gut 24: 38-41.
10. Chapman RW, Kelly PM, Heryet A et al (1988) Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29: 422-427.
11. Crippin JS & Lindor KD (1992) Primary sclerosing cholangitis: etiology and immunology. European Journal of Gastroenterology and Hepatology 4: 261-265.
12. Delbet P (1924) Retrecissement du choledoque cholecystoduodenostomie. Bulletins et Memoires de la Societe Nationale de Chirurgie de Paris 50: 1144-1146.
13. Dickson ER, Murtaugh PA, Wiesner RH et al (1992) Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103: 1893-1899.
14. Donaldson PT, Farrant JM, Wilkinson ML et al (1991) Dual association of HLA-DR2 and DR3 with primary sclerosing cholangitis. Hepatology 13: 129-133.
15. Duerr RH, Targan SR, Landers CJ et al (1991) Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100: 1385-1391.
16. Eade MM & Brooke BN (1969) Portal bacteremia in cases of ulcerative colitis submitted to colectomy. Lancet 1: 1008-1009.
17. Farrant JM, Hayllar KM, Wilkinson ML et al (1991) Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100: 1710-1717.
18. Fausa O, Schrumpf E & Elgjo K (1991) Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Seminars in Liver Disease 11: 31-39.
19. Gross JB, Wiesner RH, LaRusso NF et al (1985) Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology 89: 272-278.
20. Hay JE, Wiesner RH, Shorter RG et al (1988) Primary sclerosing cholangitis and celiac disease: a novel association. Annals of Internal Medicine 109: 713-717.
21. Hay JE, Lindor KD, Wiesner RH et al (1991) The metabolic bone disease of primary sclerosing cholangitis. Hepatology 14: 257-261.
22. Helzberg JH, Peterson JM & Boyer JL (1987) Improved survival with primary sclerosing cholangitis: a review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 92: 1869-1875.
23. Hobson CH, Butt TJ, Ferry DM et al (1988) Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology 94: 1006-1013.
24. Holzbach RT, March ME, Freedman MR et al (1980) Portal vein bile acids in patients with severe inflammatory bowel disease. Gut 21: 428-435.
25. Jorge AD, Elsey C & Ahumada J (1987) Family incidence or primary sclerosing cholangitis associated with immunologic diseases. Endoscopy 19: 390-395.
26. Knox TA & Kaplan MM (1994) A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 106: 494-499.
27. LaRusso NF, Wiesner RH, Ludwig J et al (1988) Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 95: 1036-1042.
28. Lindor KD (1997) Ursodiol for primary sclerosing cholangitis. New England Journal of Medicine 336: 691-695.
29. Lindor KD, Wiesner RH, Katzmann JA et al (1987) Lymphocyte subsets in primary sclerosing cholangitis. Digestive Diseases and Sciences 32: 720-725.
30. Lo SK, Hermann R, Chapman RW et al (1992) Ursodeoxycholic acid in primary sclerosing cholangitis: a double-blind placebo controlled trial. Hepatology 16: 92A (abstract).
31. Ludwig J (1991) Small-duct primary sclerosing cholangitis. Seminars in Liver Disease 11: 11-24.
32. Ludwig J, LaRusso NF & Wiesner RH (1990) The syndrome of primary sclerosing cholangitis. Progress in Liver Disease 9: 555-566.
33. Ludwig J, Barham SS, LaRusso NF et al (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1: 632-640.
34. McEntee G, Wiesner RH, Rosen C et al (1991) A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. Transplantation Proceedings 23: 1563-1564.
35. Marsh JWJ, Iwatsuki S, Makowka L et al (1988) Orthotopic liver transplantation for primary sclerosing cholangitis. Annals of Surgery 207: 21-25.
36. Minuk GY, Rascanin N, Paul RW et al (1987) Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis. Journal of Hepatology 5: 8-13.
37. Miros M, Kerlin P, Walker N et al (1991) Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 32: 1369-1373.
38. Morecki P, Glaser JH, Cho S et al (1982) Biliary atresia and reovirus type 3 infection. New England Journal of Medicine 307: 481-484.
39. Nichols JC, Gores GJ, LaRusso NF et al (1993) Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clinic Proceedings 68: 874-879.
40. Palmer KR, Duerden BI & Holdsworth CD (1980) Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 21: 851-854.
41. Prochazka EJ, Terasaki PI, Park MS et al (1990) Association of primary sclerosing cholangitis with HLA-DRw52A. New England Journal of Medicine 322: 1842-1844.
42. Rabinovitz M, Gavelek JS, Schade RR et al (1990) Does primary sclerosing cholangitis occurring in association with inflammatory bowel diseaase differ from that occurring in the absence of inflammatory bowel disease: a study of thirty-six subjects. Hepatology 11: 7-11.
43. Rosen CB, Nagorney DM, Wiesner RH et al (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Annals of Surgery 213: 21-25.
44. Skolkin MD, Alspaugh JP, Casarella WJ et al (1989) Sclerosing cholangitis: palliation with percutaneous cholangioplasty. Radiology 170: 199-206.
45. Snook JA, Chapman RW, Flemming K et al (1989a) Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clinical Experimental Immunology 76: 30-33.
46. Snook JA, Chapman RW, Sachdev GK et al (1989b) Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis. Journal of Hepatology 9: 36-41.
47. Stonnington CM, Phillips SF, Melton LJ III et al (1987) Chronic ulcerative colitis: incidence and prevalence in a community. Gut 28: 402-409.
48. Van Thiel DH, Wright HI & Gavaler JS (1992) Ursodeoxycholic acid (UDCA) therapy for primary sclerosing cholangitis (PSC): preliminary report of a randomized controlled trial. Hepatology 16: 62A (abstract).
49. Van Thiel DH, Carroll P, Abu-Elmagd K et al (1995) Tacrolimus (FK506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. American Journal of Gastroenterology 90: 455-461.
50. Vierling JM (1994) Hepatobiliary disease in patients with inflammatory bowel disease. In Targan S & Shanahan F (eds) Inflammatory Bowel Disease: From Bench to Bedside, pp 654-661. Baltimore: Williams & Wilkins.
51. Wiesner RH (1994) Current concepts in primary sclerosing cholangitis. Mayo Clinic Proceedings 69: 969-982.
52. Wiesner RH (1994) Contemporary Internal Medicine 6: 37-46.
53. Wiesner RH, LaRusso NF, Ludwig J et al (1985) Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 88: 108-114.
54. Wiesner RH, Grambsch PM, Dickson ER et al (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10: 430-436.
55. Wiesner RH, Steiner B, LaRusso NF et al (1991) A controlled clinical trial evaluating cyclosporine in the treatment of primary sclerosing cholangitis. Hepatology 14: 63A (abstract).